Home » PAR'S PROFIT JUMPS 212%
PAR'S PROFIT JUMPS 212%
Par Pharmaceutical on Monday announced income growth of 212 percent and sales growth of 78 percent, exceeding analysts' expectations and underlining the strength of the generic drug industry.
Red Herring
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May